Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis

Adding chemotherapy to radical cystectomy (RC) may improve outcome. Neoadjuvant treatment is advocated by guidelines based on meta-analysis data but is severely underused in clinical practice. Adjuvant treatment of patients at risk could be an alternative.

We analyzed a sample of 798 patients who underwent RC between 1993 and 2011 for high-risk superficial or muscle-invasive urothelial or undifferentiated bladder cancer, of which 23% received adjuvant cisplatin-based chemotherapy and %5 received neoadjuvant chemotherapy. The use of adjuvant chemotherapy was an independent predictor of decreased overall mortality (hazard ratio [HR]: 0. 50; 95% confidence interval [CI], 0. 38-0. 66; p

Adjuvant chemotherapy may decrease overall and bladder cancer-specific mortality after radical cystectomy (RC). Future trials should directly compare the concepts of neoadjuvant and adjuvant application of chemotherapy in candidates for RC.

European urology. 2015 Jul 17 [Epub ahead of print]

Michael Froehner, Rainer Koch, Ulrike Heberling, Vladimir Novotny, Sven Oehlschlaeger, Matthias Hübler, Gustavo B Baretton, Oliver W Hakenberg, Manfred P Wirth

Department of Urology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. Department of Medical Statistics and Biometry, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. , Department of Urology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. , Department of Urology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. , Department of Urology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. , Department of Anesthesiology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. , Department of Pathology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany. , Department of Urology, University of Rostock, Rostock, Germany. , Department of Urology, University Hospital "Carl Gustav Carus," Technische Universität Dresden, Dresden, Germany.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe